CorMedix Inc.CRMDNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank7
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P7
Near historical low
vs 3Y Ago
-2.2x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-48.61%
202464.89%
202377.93%
202222.39%
202117.79%
20200.00%
2019-100.00%
2018-6.68%
2017-2.60%
2016-13.45%